News

Healthcare AI company Aidoc raised $150 million in new financing as it aims to expand its clinical artificial intelligence solutions into oncology and cardiovascular disease to aid clinicians with decision-making and diagnosis. The company is breaking new ground with foundation-model-powered clinical AI solutions—it secured Food and Drug Administration clearance for its CADt AI solution back in February. The clearance applies to Aidoc's rib fractures triage solution.